DocGo Inc. (DCGO)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DocGo Inc. (“DocGo” or “the Company”) (NASDAQ: DCGO). Investors who purchased DocGo securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether DocGo has violated federal securities laws.

Investigation Details:

Before the market opened on January 10, 2024, Fuzzy Panda Research released a report entitled “DocGo – Allegations of Fraudulent Billing Practices & Forging of Documents.” Fuzzy Panda stated that “through former employee interviews and never before seen lawsuits we discovered serious allegations that DocGo (DCGO) has allegedly been committing Medicare fraud and having employees forge signatures on medical documents.” On this news, DocGo’s stock fell $1.80 per share, or 37.58%, on January 10, 2024, and closed at $2.99 per share.

What’s Next?

If you are aware of any facts relating to this investigation or purchased DocGo securities, you can assist this investigation. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.


Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Nathanson

332-239-2660 | [email protected]